Latest Insider Transactions at Royalty Pharma PLC (RPRX)
This section provides a real-time view of insider transactions for Royalty Pharma PLC (RPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Royalty Pharma plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Royalty Pharma plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2020
|
Legorreta Pablo G. CEO, Chairman of the Board |
BUY
Open market or private purchase
|
Indirect |
20,000
+50.0%
|
$560,000
$28.0 P/Share
|
|
Jun 16
2020
|
Legorreta Pablo G. CEO, Chairman of the Board |
BUY
Conversion of derivative security
|
Indirect |
493,750
+50.0%
|
-
|
|
Dec 12
2002
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
40,010
-29.26%
|
$1,640,410
$41.98 P/Share
|